Armistice Capital, LLC Axonics, Inc. Transaction History

Armistice Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $17 Million - $24.4 Million	-388,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $19.4 Million - $28.5 Million	388,000 New	388,000 $21.7 Million
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $22.4 Million - $29.7 Million	-378,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $2.06 Million - $2.68 Million	-40,000 Reduced 9.57%	378,000 $24 Million
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $8.35 Million - $10.2 Million	170,000 Added 68.55%	418,000 $25 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $4.56 Million - $5.56 Million	108,000 Added 77.14%	248,000 $12.4 Million
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $4.95 Million - $7.15 Million	140,000 New	140,000 $7.15 Million

241

42.8M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.42B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.